Jmd Growth Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 11-12-2024
- Paid Up Capital ₹ 0.10 M
as on 11-12-2024
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
About Jmd Growth Life Sciences
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Uttam Mehta, Teena Mehta, and Lakshmi Mahto serve as directors at the Company.
- CIN/LLPIN
U24232DL2010PTC201309
- Company No.
201309
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Apr 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Jmd Growth Life Sciences Private Limited offer?
Jmd Growth Life Sciences Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Nutraceuticals & Dietary Supplements, Nutritional Supplements, Whey Protein, Protein Powder, Weight Gain Nutrition, Ayurvedic Pain Relief Oil, Ayurvedic & Herbal Health Supplement, Herbal Sexual Health Supplement.
Who are the key members and board of directors at Jmd Growth Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Uttam Mehta  | Director | 08-Apr-2010 | Current |
| Teena Mehta | Director | 03-Sep-2016 | Current |
| Lakshmi Mahto | Director | 01-Jul-2022 | Current |
Financial Performance of Jmd Growth Life Sciences.
Jmd Growth Life Sciences Private Limited, for the financial year ended 2015, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Jmd Growth Life Sciences?
In 2016, Jmd Growth Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jmd Growth Life Sciences?
Unlock and access historical data on people associated with Jmd Growth Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jmd Growth Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jmd Growth Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
